Profound Medical
PROF | NASDAQ
$7.34
-$0.08 (-1.08%)
At close: Nov 16, 2026, 4:00 PM ET
$7.20
-$0.14 (-1.91%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-1.08%
(1D)No price chart data available for 1D timeframe.
Rating
55.8
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #174/1021 (Top 17%)
Key Statistics
Market Data
Market Cap $268.84M
1D Range
7.18 7.42
52W Range
5.06 8.65
Valuation (TTM)
PE -14.39
PB 6.32
EV/EBITDA -7.31
Valuation (NTM)
Forward PE N/A
Forward PEG 0.24
Price Target $11.00
Cash Flow
FCF Yield -11.8%
SBC Adj. FCF Yield -13.1%
SBC Impact -11.2%
Margins
Gross Margin 73.8%
Operating Margin -145.1%
FCF Margin -134.9%
Growth (CAGR)
Revenue 3Y | 5Y 50.6% |
17.8%
Dil EPS 3Y | 5Y 39.1% |
15.3%
FCF 3Y | 5Y -11.5% |
-10.8%
Returns
ROA -55.5%
ROE -59.2%
ROIC -67.0%
Financial Health
Net Cash
$33.24M
Current Ratio 4.54
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative p...
Sector Healthcare
Industry Medical - Devices
Employees 162
IPO Date Oct 29, 2019
Website www.profoundmedical.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
-$0.21
Miss -10.53%
YoY:
+19.23% REV
$9.83M
Beat +11.45%
YoY:
+87.94%Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$11.00
Upside
+49.86%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove PROF